Pharmacy Practice Pharmacy Workforce

ASHP Publishes Reports Exploring Pharmacy's Role in Future of Healthcare Delivery

Published: February 16, 2021
ASHP Press Release

Consensus Reports from ASHP/ASHP Foundation, Vizient Pharmacy Network Offer Vision for Optimized Medication Use, Pharmacy Practice in Health Systems

ASHP today announced the publication of two landmark reports that articulate a futuristic vision for pharmacy practice, including expanded roles for the pharmacy enterprise in healthcare organizations. The 2021 ASHP/ASHP Foundation Pharmacy Forecast Report and the Vizient Pharmacy Network High-Value Pharmacy Enterprise (HVPE) framework, published in AJHP, outline opportunities for pharmacy leaders to advance patient-centered care, population health, and the overall well-being of their organizations.

 “During these unprecedented times, it is more important than ever for pharmacy leaders to demonstrate the value pharmacy services contribute to the health of patients and the healthcare system," said ASHP CEO Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP, and Karl Matuszewski, M.S., Pharm.D., Vizient Vice President of Member Connections. "The HVPE framework and the Pharmacy Forecast, used in conjunction with the ASHP Practice Advancement Initiative 2030 recommendations, are essential tools to help pharmacy leaders build a comprehensive, future-focused, patient-centered pharmacy enterprise that delivers optimal outcomes through safe and effective medication use."

ASHP and the ASHP Foundation issue the Pharmacy Forecast annually to identify emerging issues and serve as a tool for dynamic strategic planning for pharmacy departments and health systems. The 2021 report is based on a survey on the likelihood of 42 potential impactful events occurring within the next five years in healthcare. A 17-member committee of pharmacy practice executives and specialists advised on the content of the survey, which was sent to a national panel of 319 experts in health-system pharmacy. The Pharmacy Forecast includes sections on the global supply chain, access to healthcare, analytics and big data, healthcare financing and delivery, patient safety, the pharmacy enterprise, and the pharmacy workforce. The report offers actionable, strategic recommendations for organizations to prepare for and respond to these emerging trends and issues that impact patient care.


The survey responses and recommendations in the 2021 Pharmacy Forecast reflect the disruptions caused by the COVID-19 pandemic and related economic crisis. Asked to predict trends for the next five years, 91% of the surveyed pharmacy directors agreed that at least 25 states will enact provisions to expand pharmacists’ scope of practice during public health emergencies. More than 90% of the survey respondents expect a significant expansion of patient access to telehealth in rural and other underserved locations. The Forecast recommends that pharmacy leaders build on the expanded use of telehealth during the coronavirus pandemic to implement permanent telepharmacy services to enhance patients' medication-related outcomes, particularly those in underserved areas.

The global nature of the U.S. drug supply chain was initially a concern during the COVID-19 pandemic. A vast majority of leaders in the survey believed that global issues such as trade restrictions, pandemics, or climate change increase the potential for drug shortages. The Pharmacy Forecast suggests that health systems collaborate with other organizations and local and state agencies to plan for pandemic-related surges or distribution of scarce resources such as vaccines.

The HVPE framework establishes eight domains that address an expansive list of topics, including patient care services in the ambulatory, specialty pharmacy, and inpatient settings; safety and quality; pharmacy workforce; information technology, including data analytics and information management; business practices; and leadership. Consensus participants set a goal of adopting the 94 evidence-based statements and 336 performance elements in health system–based medication-use processes and pharmacy practice by 2025.

The Pharmacy Forecast and the HVPE framework are published online ahead of print and will appear in print in the March 15, 2021 issue of AJHP. The Pharmacy Forecast report was supported by a donation from Omnicell to the ASHP Foundation David A. Zilz Leaders for the Future Fund.

# # #

About ASHP

ASHP represents pharmacists who serve as patient care providers in acute and ambulatory settings. The organization’s nearly 58,000 members include pharmacists, student pharmacists, and pharmacy technicians. For 79 years, ASHP has been at the forefront of efforts to improve medication use and enhance patient safety. For more information about the wide array of ASHP activities and the many ways in which pharmacists advance healthcare, visit ASHP’s website,, or its consumer website,

About the ASHP Foundation
The ASHP Foundation was established in 1968 by ASHP as a nonprofit, tax-exempt organization. As the philanthropic arm of ASHP, the Foundation shares ASHP's vision that medication use will be optimal, safe, and effective for all people all of the time. Our mission is to support ASHP by advancing the professional practice of pharmacists and the pharmacy workforce by funding research and education that improves health outcomes through optimal, safe, and effective medication use.

Posted February 16, 2021

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information